Company Filing History:
1 out of 4 
1 out of 1 Years Active: 2022
Title: Thomas Amort: Innovator in Nucleotide Conversion
Introduction
Thomas Amort is a notable inventor based in Innsbruck, Austria. He has made significant contributions to the field of molecular biology, particularly in the conversion of nucleotides. His innovative work has implications for both research and medical applications.
Latest Patents
Thomas Amort holds a patent for "Osmiumtetroxide-based conversion of RNA and DNA containing thiolated nucleotides." This patent provides compositions and methods for the conversion of thiolated nucleotides, as well as their subsequent detection in RNA or DNA. Additionally, it includes methods for the metabolic labeling of RNA and DNA through the incorporation of thiolated nucleotides, followed by their conversion and detection.
Career Highlights
Throughout his career, Thomas has worked with prestigious institutions such as the University of Innsbruck and the Medical University of Innsbruck. His research has focused on advancing the understanding of nucleic acids and their functionalities.
Collaborations
Thomas has collaborated with esteemed colleagues, including Ronald Micura and Alexandra Lusser. Their joint efforts have contributed to the advancement of knowledge in the field of molecular biology.
Conclusion
Thomas Amort's innovative work in nucleotide conversion showcases his dedication to advancing scientific research. His contributions have the potential to impact various applications in molecular biology and medicine.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.